| Product Focus :: EVK-001
EVK-001 is a novel gastrointestinal product in late stage development for the treatment of patients with diabetic gastroparesis. After the acquisition of EVK-001, Evoke has continued development work on the product and initiated additional clinical trials. Product registration will occur following a Phase 3 clinical trial which is expected to initiate in 2012. Evoke holds rights to intellectual property associated with EVK-001 granted by the United States Patent & Trademark Office with expiration dates through 2021.
|
